16 November 2021
MOH says sofosbuvir will be given to medical tourists at private hospitals after procuring the drug under a voluntary licence; WTO rules only allow compulsory licensing for public non-commercial use.
Tag: sofosbuvir
7 August 2020
Remdesivir is not in the Malaysian treatment protocol for Covid-19, says Dr Adham Baba.
29 July 2020
Charles Santiago says Malaysians can’t afford the total remdesivir price of RM10,000 per patient.
17 July 2020
MOH said last November that 4,500 Malaysians were treated with generics of sofosbuvir.
12 May 2020
Unwarranted high prices for medications could lead to preventable deaths, said a study.
4 December 2019
Gilead announced in August 2017 the expansion of its sofosbuvir voluntary licensing programme to Malaysia.
26 November 2019
The Drugs for Neglected Diseases initiative (DNDi) plans to register ravidasvir in Malaysia next year.
13 November 2019
Only over 50,000 high-risk people were screened this year, out of an estimated 500,000 Malaysians living with Hepatitis C.
20 September 2019
Voluntary licences can lead to an extra 54 to 69 people annually receiving Hepatitis C treatment per 1,000 individuals diagnosed.